HIV Vaccine Trials Begin Leading to Strong Hopes for AIDS Cure

Understanding Public Debate on Nanotechnologies: Options for Framing Public Policy -- The Innovation Society (2/8/2010) The Governance and Ethics Unit of the Directorate General for Research (DG Research) of the European Commission (EC) has published an overview paper on options for framing public policy on nanotechnologies. [More]

UN Patent Filings Dropped for 1st Time Since 1978 -- ABC news (2/8/2010) The United Nations World Intellectual Property Organization (WIPO), an entity through which a company can, for a fee, file a request for patent protection in any or all of the 142 countries that have subscribed to the U.N.'s Patent Cooperation Treaty, reported that the number of international patent filings dropped last year for the first time since 1978. [More]

TECHNOLOGY: Science Panel Probes Renewable Energy's Current Use of China's Rare Metals -- Environment & Energy Daily (2/8/2010) A United States House of Representatives Science and Technology subcommittee this week will hold a hearing on rare earth mineral production and the resource's role in the growing clean energy industry. [More]

Nanofood for Thought -- Nature Nanotechnology (2/5/2010) This editorial, in the journal Nature Nanotechnology, is in response to the recent report, "Nanotechnologies and Food", released in January by the House of Lords Science and Technology Committee, United Kingdom, that criticized the food industry for failing to be transparent about its research into the uses of nanotechnologies and nanomaterials. [More]

More News...

Learn how to include these headlines on your own website by clicking here.

Please email us if you require text-only versions of the daily emails.

HIV Vaccine Trials Begin Leading to Strong Hopes for AIDS Cure

As tagged by Meridian Institute:

Related Forums:








our team contact us site map	HIV Vaccine Trials Begin Leading to Strong Hopes for AIDS Cure Summary posted by Meridian on 3/30/2008 Source: AZoNano.com Author: n/a U.S. company NanoViricides have announced that it will soon be starting preliminary animal trials of its HIV therapeutic drug HivCide-I. NanoViricides CEO Eugene Seymour said, “The need for more therapeutic alternatives to combat HIV is greater than ever, especially after the complete failure of two highly-publicized HIV vaccine trials, the first conducted by VaxGen and the second by Merck.” Howard Fields of NanoViricides explained that controlling viremia, the presence of a virus in the blood, “is the most important factor in keeping HIV infection from developing into symptomatic AIDS,” and that the company’s drugs are “designed precisely for controlling viremia by eliminating the circulating virus.” The company’s president Anil R. Diwan said that the study will be followed up by a “major government research institution” later this year. The article can be viewed online at the link below. The original article may still be available at www.azonano.com/news.asp?newsID=6173 As tagged by Meridian Institute: Health And Medical: Diseases Regions: North America Stakeholders: Industry Related Forums: Health and Medical print format	NDN Home Subscribe Manage Subscription Search News Archives Understanding Public Debate on Nanotechnologies: Options for Framing Public Policy -- The Innovation Society (2/8/2010) The Governance and Ethics Unit of the Directorate General for Research (DG Research) of the European Commission (EC) has published an overview paper on options for framing public policy on nanotechnologies. [More] UN Patent Filings Dropped for 1st Time Since 1978 -- ABC news (2/8/2010) The United Nations World Intellectual Property Organization (WIPO), an entity through which a company can, for a fee, file a request for patent protection in any or all of the 142 countries that have subscribed to the U.N.'s Patent Cooperation Treaty, reported that the number of international patent filings dropped last year for the first time since 1978. [More] TECHNOLOGY: Science Panel Probes Renewable Energy's Current Use of China's Rare Metals -- Environment & Energy Daily (2/8/2010) A United States House of Representatives Science and Technology subcommittee this week will hold a hearing on rare earth mineral production and the resource's role in the growing clean energy industry. [More] Nanofood for Thought -- Nature Nanotechnology (2/5/2010) This editorial, in the journal Nature Nanotechnology, is in response to the recent report, "Nanotechnologies and Food", released in January by the House of Lords Science and Technology Committee, United Kingdom, that criticized the food industry for failing to be transparent about its research into the uses of nanotechnologies and nanomaterials. [More] More News... Learn how to include these headlines on your own website by clicking here. Please email us if you require text-only versions of the daily emails.